Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Rash from EGFRI treatment can indicate both side effects and treatment effectiveness.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Tadalafil and Finasteride may help treat aggressive melanoma.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Tofacitinib treatment for hair loss may worsen acne.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.